Product Description
SM04554 is a novel small molecule, topical scalp treatment for AGA targeting the Wnt pathway, a pathway known to regulate hair growth.
Mechanisms of Action: Wnt Activator
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Biosplice Therapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Alopecia Areata
Phase 1: Alopecia
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| SM04554-AGA-05 | P3 |
Completed |
Alopecia Areata |
2020-12-31 |
45% |
| SM04554-AGA-04 | P2 |
Completed |
Alopecia Areata |
2016-04-01 |
|
| None | P1 |
Completed |
Alopecia |
2015-11-26 |
|
| SM04554-AGA-02 | P2 |
Completed |
Alopecia Areata |
2015-11-01 |